Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 601, Issue 1-2, 2006, Pages 191-201

  Godthelp, Barbara C ^a   van Buul, Paul P W ^a   Jaspers, Nicolaas G J ^b   Elghalbzouri Maghrani, Elhaam ^a   van Duijn Goedhart, Annemarie ^a   Arwert, Fré ^c   Joenje, Hans ^c   Zdzienicka, Małgorzata Z ^a,d  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

BRCA2; Chromosomal instability; DNA damaging agents; Fanconi anemia; Radioresistant DNA synthesis

Indexed keywords

BRCA2 PROTEIN; MESYLIC ACID METHYL ESTER; MITOMYCIN C;

ANIMAL CELL; ARTICLE; CANCER SUSCEPTIBILITY; CELL CYCLE S PHASE; CELL SURVIVAL; CONTROLLED STUDY; DNA CROSS LINKING; DNA SYNTHESIS; FANCONI ANEMIA; FIBROBLAST; GENE MUTATION; GENETIC IDENTIFICATION; GENOMIC INSTABILITY; HOMOLOGOUS RECOMBINATION; HYPERSENSITIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RADIOSENSITIVITY; RODENT; SISTER CHROMATID EXCHANGE; ULTRAVIOLET RADIATION; X RAY;

BLEOMYCIN; BRCA2 PROTEIN; CELL SURVIVAL; CELLS, CULTURED; CHROMOSOME ABERRATIONS; DNA DAMAGE; DNA REPAIR; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; FIBROBLASTS; HUMANS; METHYL METHANESULFONATE; MITOMYCIN; SISTER CHROMATID EXCHANGE;

RODENTIA;

EID: 33749639069     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2006.07.003     Document Type: Article

References (54)

1. Auerbach A.D., Buchwald M., and Joenje H. Fanconi anemia. In: Vogelstein B., and Kinzler K.W. (Eds). The Genetic Basis of Human Cancer (1998), McGraw-Hill, New York 317-332
2. Joenje H., and Patel K.J. The emerging genetic and molecular basis of Fanconi anemia. Nat. Rev. Genet. 2 (2001) 446-457
3. Levitus M., Rooimans M.A., Steltenpool J., Cool N.F.C., Oostra A.B., Mathew C.G., Hoatlin M.E., Waisfisz Q., Arwert F., de Winter J.P., and Joenje H. Heterogeneity in Fanconi anemia: evidence for two genetic subtypes. Blood 103 (2004) 2498-2503
4. Timmers C., Taniguchi T., Hejna J., Reifsteck C., Lucas L., Bruun D., Thayer M., Cox B., Olson S., and D'Andrea A. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol. Cell 7 (2001) 241-248
5. Meetei A.R., de Winter J.P., Medhurst A.L., Wallisch M., Waisfisz Q., van de Vrugt H.J., Oostra A.B., Yan Z., Ling C., Bishop C.E., Hoatlin M.E., Joenje H., and Wang W. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet. 35 (2003) 165-170
6. Meetei A.R., Levitus M., Xue Y., Medhurst A.L., Zwaan M., Ling C., Rooimans M.A., Bier P., Hoatlin M., Pals G., de Winter J.P., Wang W., and Joenje H. X-linked inheritance of Fanconi anemia complementation group B. Nat. Genet. 36 (2004) 1219-1224
7. Howlett N.G., Taniguchi T., Olson S., Waisfisz Q., de Die-Smulders C., Persky N., Grompe M., Joenje H., Pals G., Ikeda H., Fox E.A., and D'Andrea A.D. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297 (2002) 606-609
8. Levitus M., Waisfisz Q., Godthelp B.C., de Vries Y., Hussain S., Wiegant W.W., Elghalbzouri-Maghrani E., Steltenpool J., Rooimans M.A., Pals G., Arwert F., Mathew C.G., Zdzienicka M.Z., Hiom K., De Winter J.P., and Joenje H. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group. J. Nat. Genet. 37 (2005) 934-935
9. Meetei A.R., Medhurst A.L., Ling C., Xue Y., Singh T.R., Bier P., Steltenpool J., Stone S., Dokal I., Mathew C.G., Hoatlin M., Joenje H., de Winter J.P., and Wang W. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat. Genet. 37 (2005) 958-963
10. Garcia-Higuera I., Taniguchi T., Ganesan S., Meyn M.S., Timmers C., Hejna J., Grompe M., and D'Andrea A.D. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7 (2001) 249-262
11. Medhurst A.L., Huber P.A.J., Waisfisz Q., de Winter J.P., and Mathew C.G. Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway. Hum. Mol. Genet. 10 (2001) 423-429
12. Folias A., Matkovic M., Bruun D., Reid S., Hejna J., Grompe M., D'Andrea A., and Moses R. BRCA1 interacts directly with the Fanconi anemia protein FANCA. Hum. Mol. Genet. 11 (2002) 2591-2597
13. Hussain S., Witt E., Medhurst A.L., Ashworth A., and Mathew C.G. Direct interaction of the Fanconi anemia protein FANCG with BRCA2/FANCD1. Hum. Mol. Genet. 12 (2003) 2503-2510
14. Taniguchi T., Garcia-Higuera I., Xu B., Andreassen P.R., Gregory R.C., Kim S.-T., Lane W.S., Kastan M.B., and D'Andrea A.D. Convergence of the Fanconi anemia and Ataxia telangiectasia signaling pathways. Cell 109 (2002) 459-472
15. Thompson L.H., Hinz J.M., Yamada N.A., and Jones N.J. How Fanconi anemia proteins promote the four Rs: replication, recombination, repair, and recovery. Environ. Mol. Mutagen. 45 (2005) 128-142
16. Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., Collins N., Gregory S., Gumbs C., Micklem G., Barfoot R., Hamoudi R., Patel S., Rices C., Biggs P., Hashim Y., Smith A., Connor F., Arason A., Gudmundsson J., Ficenec D., Kelsell D., FordTonin D.P., Bishop D.T., Spurr N.K., Ponder B.A.J., Eeles R., Peto J., Devilee P., Cornelisse C., Lynch H., Narod S., Lenoir G., Egilsson V., Barkadottir R.B., Easton D.F., Bentley D.R., Futreal P.A., Ashworth A., and Stratton M.R. Identification of the breast cancer susceptibility gene BRCA2. Nature 378 (1995) 789-792
17. Rahman N., and Stratton M.R. The genetics of breast cancer susceptibility. Annu. Rev. Genet. 32 (1998) 95-121
18. The Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers. J. Natl. Cancer. Inst. 91 (1999) 1310-1316
19. Venkitaraman A.R. Breast cancer genes and DNA repair. Science 286 (1999) 1100-1102
20. West S.C. Molecular views of recombination proteins and their control. Nat. Rev. 4 (2003) 1-11
21. Pellegrini L., and Ventikaraman A. Emerging functions of BRCA2 in DNA recombination. Trends Biochem. Sci. 29 (2004) 310-316
22. Bochkarev A., and Bochkareva E. From RPA to BRCA2: lessons from single-stranded DNA binding by the OB-fold. Curr. Opin. Struct. Biol. 14 (2004) 36-42
23. Esashi F., Christ N., Gannon J., Liu Y., Jasin M., and West S.C. CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair. Nature 434 (2005) 598-604
24. Suzuki A., Pompa J.-L., Hakem R., Elia A., Yoshida R., Mo R., Nishina H., Chuang T., Wakeham A., Itie A., Koo W., Billia P., Ho A., Fukumoto M., Hui C.C., and Mak T.W. Brca2 is required for embryonic cellular proliferation in the mouse. Genes Dev. 11 (1997) 1242-1252
25. Connor F., Bertwistle D., Mee P.J., Ross G.M., Swift S., Grigorieva E., Tybulewicz V.L., and Ashworth A. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nat. Genet. 17 (1997) 423-430
26. Friedman L.S., Thistlethwaite F.C., Patel K.J., Yu V.P., Lee H., Venkitaraman A.R., Abel K.J., Carlton M.B., Hunter S.M., Colledge W.H., Evans M.J., and Ponder B.A. Thymic lymphomas in mice with a truncating mutation in Brca2. Cancer Res. 58 (1998) 1338-1343
27. McAllister K.A., Bennett L.M., Houle C.D., Ward T., Malphurs J., Collins N.K., Cachafeiro C., Haseman J., Goulding E.H., Bunch D., Eddy E.M., Davis B.J., and Wiseman R.W. Cancer susceptibility of mice with a homozygous deletion in the COOH-terminal domain of the Brca2 gene. Cancer Res. 62 (2002) 990-994
28. Goggins M., Schutte M., Lu J., Moskaluk C.A., Weinstein C.L., Petersen G.M., Yeo C.J., Jackson C.E., Lynch H.T., Hruban R.H., and Kern S.E. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res. 56 (1996) 5360-5364
29. Chen J., Silver D.P., Walpita D., Cantor S.B., Gazdar A.F., Tomlinson G., Couch F.J., Weber B.L., Ashley T., Livingston D.M., and Scully R. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol. Cell 2 (1998) 317-328
30. Godthelp B.C., Arwert F., Joenje H., and Zdzienicka M.Z. Impaired DNA damage-induced nuclear Rad51 foci formation uniquely characterizes Fanconi anemia group D1. Oncogene 21 (2002) 5002-5005
31. Godthelp B.C., Wiegant W.W., Waisfisz Q., Medhurst A.L., Arwert F., Joenje H., and Zdzienicka M.Z. Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2. Mutat. Res. 594 (2006) 39-48
32. Ohashi A., Zdzienicka M.Z., Chen J., and Couch F.J. Fanconi anemia complementation group D2 functions independently of BRCA2- and Rad51-associated homologous recombination in response to DNA damage. J. Biol. Chem. 280 (2005) 14877-14883
33. Takata M., Sasaki M.S., Tachiiri S., Fukushima T., Sonoda E., Schild D., Thompson L.H., and Takeda S. Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs. Mol. Cell. Biol. 21 (2001) 2858-2866
34. Thacker J. A surfeit of RAD51-like genes. Trends Genet. 15 (1999) 166-168
35. Godthelp B.C., Wiegant W.W., van Duijn-Goedhart A., Scharer O.D., van Buul P.P.W., Kanaar R., and Zdzienicka M.Z. Mammalian Rad51C contributes to DNA cross-link resistance, sister chromatid cohesion and genomic stability. Nucl. Acids Res. 30 (2002) 2172-2182
36. Tutt D., Bertwistle J., Valentine A., Gabriel S., Swift G., Ross C., Griffin J., and Thacker A. Ashworth Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences. EMBO J. 20 (2001) 4704-4716
37. Patel K.J., Yu V.P.C.C., Lee H., Thistlethwaite F.C., Evans M.J., Colledge W.H., Friedman L.S., Ponder B.A., and Ventikaraman A.R. Involvement of BRCA2 in DNA repair. Mol. Cell 1 (1998) 347-357
38. Kraakman-van der Zwet M., Overkamp W.J., van Lange R.E., Essers J., van Duijn-Goedhart A., Wiggers I., Swaminathan S., van Buul P.P.W., Errami A., Tan R.T., Jaspers N.G.J., Sharan S.K., Kanaar R., and Zdzienicka M.Z. Brca2 (XRCC11) deficiency results in radioresistant DNA synthesis and a higher frequency of spontaneous deletions. Mol. Cell. Biol. 22 (2002) 669-679
39. Zdzienicka M.Z., Jaspers N.G., van der Schans G.P., Natarajan A.T., and Simons J.W. Ataxia telangiectasia-like Chinese hamster V79 cell mutants with radioresistant DNA synthesis, chromosomal instability, and normal DNA strand break repair. Cancer Res. 49 (1989) 1481-1485
40. Perry P., and Wolff S. New Giemsa staining for the differential staining of sister chromatids. Nature 251 (1974) 156-158
41. Petrini J.H. The Mre11 complex and ATM: collaborating to navigate S phase. Curr. Opin. Cell Biol. 12 (2000) 293-296
42. Overkamp M.J.I., Rooimans M.A., Neuteboom I., Arwert F., and Zdzienicka M.Z. Genetic diversity of mitomycin C-hypersensitive Chinese hamster cell mutants: a new complementation group with chromosomal instability. Som. Cell Mol. Genet. 19 (1993) 431-437
43. Carreau M., Alon N., Bosnoyan-Collins L., Joenje H., and Buchwald M. Drug sensitivity spectra in Fanconi anemia lymphoblastoid cell lines of defined complementation groups. Mut. Res. 435 (1999) 103-109
44. Kalb R., Duerr M., Wagner M., Herterich S., Gross M., Digweed M., Joenje H., Hoehn H., and Schindler D. Lack of sensitivity of primary Fanconi's fibroblasts to UV and ionizing radiation. Radiat. Res. 161 (2004) 318-325
45. Abbott D.W., Freeman M.L., and Holt J.T. Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells. J. Natl. Cancer Inst. 90 (1998) 978-985
46. Xu B.S., and Kastan M.B. Involvement of Brca1 in S-phase and G2-phase checkpoints after ionizing irradiation. Mol. Cell. Biol. 21 (2001) 3445-3450
47. Wang X.Z., Andreassen P.R., and D'Andrea A.D. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol. Cell. Biol. 24 (2004) 5850-5862
48. Sala-Trepat M., Rouillard D., Escarceller M., Laquerbe A., Moustacchi E., and Papadopoulo D. Arrest of S-phase progression is impaired in Fanconi anemia cells. Exp. Cell Res. 260 (2000) 208-215
49. Centurion S.A., Kou H.-R., and Lambert W.L. Damage-resistant DNA synthesis in Fanconi anemia cells treated with a DNA cross-linking agent. Exp. Cell Res. 260 (2000) 216-221
50. Pichierri P., and Rosselli F. The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. EMBO J. 23 (2004) 1178-1187
51. Bartek J., Lukas C., and Lukas J. Checking on DNA damage in S-phase. Nat. Rev. Mol. Cell. Biol. 5 (2004) 792-804
52. Sonoda E., Sasaki M.S., Morrison C., Yamaguchi-Iwai Y., Takata T., and Takeda S. Sister chromatid exchanges are mediated by homologous recombination in vertebrate cells. Mol. Cell. Biol. 19 (1999) 5166-5169
53. Hirsch B., Shimamura A., Moreau L., Baldinger S., Hag-alshiekh M., Bostrom B., Sencer S., and D'Andrea A.D. Association of biallelic BRCA2/FANCD2 mutations with spontaneous chromosomal instability and solid tumors of childhood. Blood 103 (2004) 2554-2558
54. Wagner J.E., Tolar J., Levran O., Scholl T., Deffenbaugh A., Satagopan J., Ben-Porat L., Mah K., Batish S.D., Kutler D., MacMillan M., Hanenburg H., and Auerbach A.D. Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia. Blood 103 (2004) 3226-3229